A Study on the efficacy of Finerenone in Management of Diabetic Nephropathy with Chronic kidney disease: A Prospective
DOI:
https://doi.org/10.48047/28tkh928Keywords:
Diabetic nephropathy, chronic kidney disease, Finerenone,Abstract
Background: Finerenone is a Non-steroidal Mineralocorticoid Antagonist. Finerenone can significantly reduce clinical manifestations and improve kidney function in patients of diabetic nephropathy with chronic kidney disease and shows its efficacy after its 1st dose. The purpose of the study was to evaluate the efficacy and safety of finerenone in management of diabetic nephropathy with chronic kidney disease.
Downloads
References
Andy KH Lim. Diabetic nephropathy – complications and treatment. International Journal of Nephrology and Renovascular Disease.2014;7361-381.
Preeti Rout; Ishwarlal Jialal. Diabetic Nephropathy.National Library of medicine.2025. 3. Csaba P Kovesdy. Epidemiology of chronic kidney disease: Kidney Int Suppl (2011) 2022 Apr;12(1):7-11
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
